Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06312293
Other study ID # STUDYAP0004
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2023
Est. completion date December 30, 2023

Study information

Verified date March 2024
Source Bahçesehir University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The use of vagus nerve stimulation (VSS), one of the examples of neuromodulation therapies, continues to increase in the medical field. Basically, invasive (iVSS) and transcutaneous VSS (tVSS) can be performed. tVSS is more preferred because of its advantages such as easy application, not requiring surgical procedure and having fewer side effects. VSS has long been an approved treatment modality in the treatment of epilepsy and refractory depression. tVSS can be administered from the auricular-auricular or posterior ear region. The vagus nerve (VS) belongs to the parasympathetic branch of the autonomic nervous system and has an effect on vital functions. There are also studies in the literature showing that VS stimulation reduces inflammation. In addition to this effect, the vagus nerve may also show analgesic activity through pain-related pathways. Due to its anti-inflammatory and analgesic effects, VSS has become a new treatment method in diseases in which various inflammatory processes are shown in the etiology such as inflammatory bowel diseases, musculoskeletal system diseases and central nervous system diseases.


Description:

There are no generally accepted values for taVNS (transcutaneous auricular vagus nerve stimulation) application parameters (amplitude, frequency, intensity, duration, side); therefore, there are heterogeneous applications in studies. In a meta-analysis on the safety profile of taVSS, local skin irritation (18. 2%), headache (3.6%), nasopharyngitis (1.7%), dizziness (1.4%) and nausea (1.1%) were reported and taVSS treatment was reported as an effective and safe treatment with these side effects, most of which were transient and did not require additional intervention. During taVNS, autonomic activities increase in favour of the parasympathetic system and this results in an increase in heart rate variability (HRV). Although an increase in HRV has been demonstrated by different studies, the factors that can predict the change in HRV are not clear. In a study by Geng et al. using taVSS, it was observed that HRV indicators representing vagal nerve activity increased significantly when stimulation was performed in the morning, but evening stimulation did not yield similar results. In addition, they found that improvements in measures of autonomic balance were more pronounced in the presence of lower vagal activity; they also found that by increasing the duration of stimulation, the effect of taVNS on HRV was not regulated by duration. In other words, HRV changes had the best effect only at the beginning of stimulation.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date December 30, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - To be 18 years of age or older, - Not having any acute or chronic health problems, - No previous transcutaneous vagus nerve stimulation application. Exclusion Criteria: - Using drugs, alcohol or smoking - Being in the post menopausal phase - Pregnancy history - Known history of acute or chronic illness - Having received any medication affecting the autonomic nervous system

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcutaneous Vagus Nerve Stimulation
All techniques used to stimulate the vagal nerve are called vagus nerve stimulation.

Locations

Country Name City State
Turkey Igdir University Igdir Central

Sponsors (1)

Lead Sponsor Collaborator
Bahçesehir University

Country where clinical trial is conducted

Turkey, 

References & Publications (5)

Carandina A, Rodrigues GD, Di Francesco P, Filtz A, Bellocchi C, Furlan L, Carugo S, Montano N, Tobaldini E. Effects of transcutaneous auricular vagus nerve stimulation on cardiovascular autonomic control in health and disease. Auton Neurosci. 2021 Dec;236:102893. doi: 10.1016/j.autneu.2021.102893. Epub 2021 Oct 9. — View Citation

Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J. Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. 2014 Nov-Dec;7(6):871-7. doi: 10.1016/j.brs.2014.07.031. Epub 2014 Jul 16. — View Citation

Peng X, Baker-Vogel B, Sarhan M, Short EB, Zhu W, Liu H, Kautz S, Badran BW. Left or right ear? A neuroimaging study using combined taVNS/fMRI to understand the interaction between ear stimulation target and lesion location in chronic stroke. Brain Stimul. 2023 Jul-Aug;16(4):1144-1153. doi: 10.1016/j.brs.2023.07.050. Epub 2023 Jul 28. — View Citation

Szeles JC, Kampusch S, Thurk F, Clodi C, Thomas N, Fichtenbauer S, Schwanzer C, Schwarzenberger S, Neumayer C, Kaniusas E. Bursted auricular vagus nerve stimulation alters heart rate variability in healthy subjects. Physiol Meas. 2021 Oct 29;42(10). doi: 10.1088/1361-6579/ac24e6. — View Citation

Trevizol AP, Shiozawa P, Taiar I, Soares A, Gomes JS, Barros MD, Liquidato BM, Cordeiro Q. Transcutaneous Vagus Nerve Stimulation (taVNS) for Major Depressive Disorder: An Open Label Proof-of-Concept Trial. Brain Stimul. 2016 May-Jun;9(3):453-454. doi: 10.1016/j.brs.2016.02.001. Epub 2016 Feb 10. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Heart Rate Variability The effectiveness of vagus nerve stimulation, its effect on autonomic nervous system activity was evaluated using heart rate variability. Polar H7 device was used for this. The heart rate was recorded non-invasively over the chest for 5 minutes and the beat-to-beat (R-R) variability was measured with Kubios software. Baseline and immediately after the intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05343039 - Technology Enhanced Adolescent Mental Health (TEAM) N/A
Recruiting NCT05992259 - Auricular Vagus Stimulation and STEMI N/A
Completed NCT04643808 - taVNS Paired With Bottle Feeding in Infants Failing Oral Feeds Early Phase 1
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Not yet recruiting NCT06121947 - Safety and Efficacy Study of Implantable Neuromodulation for Poststroke Hemiplegia N/A
Completed NCT04150627 - Effect of Breathing Maneuvers on Peripheral Glucose Metabolism N/A
Recruiting NCT06421090 - Transauricular Vagal Nerve Stimulation Improves Postoperative Delirium in Elderly Patients N/A
Recruiting NCT06421077 - Transauricular Vagus Nerve Stimulation Improves Postoperative Delirium in Elderly Patients N/A
Not yet recruiting NCT06421051 - Transauricular Vagus Nerve Stimulation Improves Postoperative Sleep Disorders in Elderly Patients. N/A
Not yet recruiting NCT06381089 - Effect Of Robotic Rehabilitation And Vagus Nerve Stimulation In Ischemia Stroke Patients N/A
Terminated NCT04256837 - Effect of Transcutaneous Electrical Auricular Stimulation of the Vagus Nerve in Kidney Transplant Recipients N/A
Completed NCT05218109 - Stress and Sleep Study N/A
Recruiting NCT05680337 - Auricular Vagus Stimulation and Heart Rate Variability N/A
Completed NCT05088135 - The Effect of Auricular Vagus Nerve Stimulation on EEG and EMG Measurement in Healthy Persons N/A
Not yet recruiting NCT05866471 - Pairing Psilocybin With Transcutaneous Auricular Vagus Nerve Stimulation Phase 1
Active, not recruiting NCT04632069 - NAC +taVNS in IDM Who Are Poor Oral Feeders Early Phase 1
Active, not recruiting NCT05230628 - Auricular Vagus Stimulation in Obesity N/A
Completed NCT06086236 - Vagus Nerve Stimulation Effects on Autonomic Nervous System Activity N/A
Completed NCT04341649 - Multi-device Testing for Autonomic Nervous System Stimulation N/A